FDA recall D-0463-2023

Breckenridge Pharmaceutical, Inc · Class II · drug

Product

Clobazam Tablets, 20 mg, CIV, 100-count bottle, Rx only, Manufactured by Centaur Pharmaceuticals Pvt. Ltd., Pune, INDIA, Distributed by: Breckenridge Pharmaceuticals, Inc., Berlin, CT 06037, NDC 51991-901-01

Reason for recall

CGMP Deviations: Potential risk of Cross Contamination

Distribution

USA nationwide.

Key facts

Status
Terminated
Initiation date
2023-03-02
Report date
2023-03-22
Termination date
2024-03-21
Voluntary/Mandated
Voluntary: Firm initiated
Location
Berlin, CT, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0463-2023